Manitoba Treatments

Manitoba provides coverage for the three available SMA treatments through their Drug Benefits Formulary and Manitoba Drug Interchangeability Formulary as part of the Exception Drug Status (EDS) Program.

 

SMA Treatments:

 

Evrysdi – Risdiplam

Spinraza – Nusinersen

Zolgensma –Onasemnogene Abeparvovec

The coverage details are not publicly shared but they can be obtained by contacting the EDS Program at Manitoba Health. Please discuss your eligibility with your health-care provider.

The information on this page was last updated in May 2024.